loading
Schlusskurs vom Vortag:
$2.43
Offen:
$2.44
24-Stunden-Volumen:
191.30K
Relative Volume:
0.28
Marktkapitalisierung:
$131.12M
Einnahmen:
$76.19M
Nettoeinkommen (Verlust:
$-1.61M
KGV:
233.10
EPS:
0.01
Netto-Cashflow:
$28.98M
1W Leistung:
+1.97%
1M Leistung:
+13.90%
6M Leistung:
+260.90%
1J Leistung:
+97.88%
1-Tages-Spanne:
Value
$2.33
$2.465
1-Wochen-Bereich:
Value
$2.27
$2.475
52-Wochen-Spanne:
Value
$0.5052
$3.22

Spero Therapeutics Inc Stock (SPRO) Company Profile

Name
Firmenname
Spero Therapeutics Inc
Name
Telefon
857-242-1600
Name
Adresse
675 MASSACHUSETTS AVENUE, CAMBRIDGE, MA
Name
Mitarbeiter
32
Name
Twitter
@spero_tx
Name
Nächster Verdiensttermin
2025-03-19
Name
Neueste SEC-Einreichungen
Name
SPRO's Discussions on Twitter

Vergleichen Sie SPRO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
SPRO
Spero Therapeutics Inc
2.33 136.75M 76.19M -1.61M 28.98M 0.01
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
421.33 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
633.37 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
434.56 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
817.41 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
181.50 40.44B 447.02M -1.18B -868.57M -6.1812

Spero Therapeutics Inc Stock (SPRO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-20 Herabstufung Evercore ISI Outperform → In-line
2022-09-23 Hochstufung Evercore ISI In-line → Outperform
2021-10-01 Herabstufung Oppenheimer Outperform → Perform
2021-01-22 Bestätigt H.C. Wainwright Buy
2020-12-16 Eingeleitet Berenberg Buy
2020-09-29 Eingeleitet Evercore ISI Outperform
2019-11-05 Bestätigt H.C. Wainwright Buy
2019-09-09 Eingeleitet Janney Buy
2018-02-09 Eingeleitet Cantor Fitzgerald Overweight
2017-11-27 Eingeleitet BofA/Merrill Neutral
2017-11-27 Eingeleitet Oppenheimer Outperform
2017-11-27 Eingeleitet Stifel Buy
Alle ansehen

Spero Therapeutics Inc Aktie (SPRO) Neueste Nachrichten

pulisher
08:15 AM

How Spero Therapeutics Inc. stock compares to industry benchmarksQuarterly Portfolio Summary & AI Based Buy and Sell Signals - newser.com

08:15 AM
pulisher
06:03 AM

How Spero Therapeutics Inc. stock reacts to inflationary pressuresPortfolio Return Summary & Fast Gaining Stock Strategy Reports - newser.com

06:03 AM
pulisher
04:36 AM

Using flow based indicators on Spero Therapeutics Inc.Quarterly Growth Report & AI Driven Stock Reports - newser.com

04:36 AM
pulisher
04:27 AM

What earnings margins imply for Spero Therapeutics Inc. (2HA) stockQuarterly Profit Summary & High Win Rate Trade Tips - newser.com

04:27 AM
pulisher
Nov 02, 2025

What analysts say about Spero Therapeutics Inc stockSupport and Resistance Levels & Free Unlock Hidden Market Opportunities - earlytimes.in

Nov 02, 2025
pulisher
Nov 02, 2025

What analysts say about China Pharma Holdings Inc stockHealthcare Stock Analysis & Rapid Profit Growth - earlytimes.in

Nov 02, 2025
pulisher
Nov 02, 2025

Will Spero Therapeutics Inc. stock keep outperforming rivalsPortfolio Update Report & Risk Adjusted Swing Trade Ideas - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Will Spero Therapeutics Inc. stock sustain high P E ratiosEarnings Recap Report & Daily Profit Maximizing Tips - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Will breakout in Spero Therapeutics Inc. lead to full recoveryTrade Risk Summary & Step-by-Step Swing Trade Plans - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

What recovery options are there for Spero Therapeutics Inc.Weekly Loss Report & Free Real-Time Market Sentiment Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Spero Therapeutics, Inc. (NASDAQ:SPRO) Short Interest Down 42.5% in October - MarketBeat

Nov 02, 2025
pulisher
Nov 02, 2025

Will Spero Therapeutics Inc. benefit from macro trendsEarnings Risk Report & Long-Term Investment Growth Plans - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

How sustainable is Spero Therapeutics Inc. stock dividend payoutMarket Activity Summary & Expert Verified Stock Movement Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

What does recent volatility data suggest for Spero Therapeutics Inc.Quarterly Market Summary & Stepwise Swing Trade Plans - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is Spero Therapeutics Inc. (2HA) stock undervalued historicallyTrade Volume Report & Free Technical Confirmation Trade Alerts - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Published on: 2025-11-01 09:23:51 - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Will Spero Therapeutics Inc. stock recover after recent drop2025 Market Outlook & Fast Exit and Entry Strategy Plans - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Spero Therapeutics Inc. stock daily chart insights2025 Trading Volume Trends & High Accuracy Swing Trade Signals - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Will Spero Therapeutics Inc. stock pay special dividendsMarket Activity Report & Daily Profit Focused Stock Screening - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Published on: 2025-10-31 10:27:16 - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Why Spero Therapeutics Inc. (2HA) stock is trending on social mediaWeekly Earnings Recap & Verified Momentum Stock Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

How to monitor Spero Therapeutics Inc. with trend dashboards2025 Trading Volume Trends & Daily Stock Trend Watchlist - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Will Spero Therapeutics Inc. stock remain a Wall Street favoriteMarket Trend Summary & Entry Point Confirmation Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Why Spero Therapeutics Inc. (2HA) stock is listed among top recommendationsWeekly Trade Summary & Accurate Entry and Exit Point Alerts - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Published on: 2025-10-30 05:46:40 - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

What MACD signals say about Spero Therapeutics Inc.Market Trend Report & Weekly Stock Breakout Alerts - newser.com

Oct 30, 2025

Finanzdaten der Spero Therapeutics Inc-Aktie (SPRO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$37.24
price down icon 0.66%
$92.89
price down icon 0.72%
$28.82
price up icon 0.84%
$104.23
price up icon 0.19%
biotechnology ONC
$311.64
price up icon 0.32%
$181.29
price down icon 4.26%
Kapitalisierung:     |  Volumen (24h):